Oakbrook Investments LLC Has $41.65 Million Stock Holdings in CME Group Inc (NASDAQ:CME)

Oakbrook Investments LLC lowered its position in CME Group Inc (NASDAQ:CME) by 0.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 197,091 shares of the financial services provider’s stock after selling 119 shares during the period. CME Group comprises approximately 2.7% of Oakbrook Investments LLC’s holdings, making the stock its 6th largest position. Oakbrook Investments LLC owned about 0.06% of CME Group worth $41,653,000 at the end of the most recent quarter.

Other large investors have also recently made changes to their positions in the company. Advantage Investment Management LLC lifted its position in CME Group by 119.0% in the second quarter. Advantage Investment Management LLC now owns 184 shares of the financial services provider’s stock valued at $36,000 after purchasing an additional 100 shares during the period. Westside Investment Management Inc. purchased a new position in CME Group in the second quarter valued at about $38,000. Private Capital Group LLC increased its holdings in CME Group by 44.9% in the second quarter. Private Capital Group LLC now owns 242 shares of the financial services provider’s stock valued at $40,000 after buying an additional 75 shares in the last quarter. Patriot Financial Group Insurance Agency LLC increased its holdings in CME Group by 209.4% in the second quarter. Patriot Financial Group Insurance Agency LLC now owns 263 shares of the financial services provider’s stock valued at $53,000 after buying an additional 178 shares in the last quarter. Finally, Motco increased its holdings in CME Group by 55.8% in the second quarter. Motco now owns 268 shares of the financial services provider’s stock valued at $52,000 after buying an additional 96 shares in the last quarter. Hedge funds and other institutional investors own 84.80% of the company’s stock.

NASDAQ CME traded down $0.83 during mid-day trading on Friday, reaching $198.17. 1,172,200 shares of the stock were exchanged, compared to its average volume of 1,518,595. The business’s fifty day simple moving average is $208.43 and its 200 day simple moving average is $201.58. The stock has a market capitalization of $70.53 billion, a PE ratio of 29.06, a PEG ratio of 3.86 and a beta of 0.18. CME Group Inc has a 1-year low of $161.05 and a 1-year high of $224.91. The company has a debt-to-equity ratio of 0.14, a quick ratio of 1.05 and a current ratio of 1.04.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, October 30th. The financial services provider reported $1.90 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.75 by $0.15. The company had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.27 billion. CME Group had a net margin of 40.93% and a return on equity of 9.54%. The company’s revenue was up 41.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.45 EPS. On average, analysts anticipate that CME Group Inc will post 6.91 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Stockholders of record on Tuesday, December 10th will be given a $0.75 dividend. This represents a $3.00 annualized dividend and a dividend yield of 1.51%. The ex-dividend date is Monday, December 9th. CME Group’s payout ratio is currently 43.99%.

CME has been the subject of a number of research analyst reports. Oppenheimer initiated coverage on shares of CME Group in a report on Monday, September 16th. They issued an “outperform” rating and a $234.00 target price for the company. Citigroup increased their target price on shares of CME Group from $220.00 to $240.00 and gave the company a “buy” rating in a report on Monday, October 21st. Wells Fargo & Co increased their target price on shares of CME Group from $200.00 to $205.00 and gave the company a “market perform” rating in a report on Thursday, October 31st. ValuEngine cut shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, October 2nd. Finally, UBS Group dropped their price objective on shares of CME Group from $220.00 to $218.00 and set a “neutral” rating for the company in a research note on Thursday, October 31st. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating and six have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $203.36.

In other CME Group news, Director Daniel R. Glickman sold 500 shares of the business’s stock in a transaction dated Wednesday, August 28th. The shares were sold at an average price of $216.01, for a total transaction of $108,005.00. Following the completion of the transaction, the director now directly owns 14,593 shares of the company’s stock, valued at approximately $3,152,233.93. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Sean Tully sold 7,200 shares of the business’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $223.13, for a total transaction of $1,606,536.00. Following the transaction, the insider now directly owns 19,923 shares of the company’s stock, valued at $4,445,418.99. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 13,636 shares of company stock valued at $3,001,008. Insiders own 1.20% of the company’s stock.

CME Group Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Read More: What is a dead cat bounce?

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.